Baxter International (BAX) Gains from Investment Securities (2009 - 2026)
Baxter International (BAX) reported Gains from Investment Securities of -$4.0 million for Q1 2026, down 300.0% year-over-year from $2.0 million in Q1 2025, and up 84.62% quarter-over-quarter from -$26.0 million in Q4 2025.
Baxter International (BAX) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Gains from Investment Securities data on file, last reported at -$4.0 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$4.0 million, down 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$64.0 million (down 611.11% YoY), and the FY2025 annual result was -$58.0 million, down 262.5% from the prior year.
- Gains from Investment Securities improved to -$4.0 million in Q1 2026 per BAX's latest filing, from -$26.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $36.0 million in Q2 2022 and troughed at -$58.0 million in Q3 2022.
- A 5-year average of -$6.8 million and a median of -$7.0 million in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities jumped 800.0% in 2022, then slumped 600.0% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at -$1.0 million in 2022, then tumbled by 600.0% to -$7.0 million in 2023, then retreated by 14.29% to -$8.0 million in 2024, then plunged by 225.0% to -$26.0 million in 2025, then surged by 84.62% to -$4.0 million in 2026.
- Business Quant data shows BAX's Gains from Investment Securities at -$4.0 million in Q1 2026, -$26.0 million in Q4 2025, and -$12.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | -26.00 Mn |
| Dec 31, 2025 | -26.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Sep 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | -22.00 Mn |
| Jun 30, 2025 | -22.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Sep 30, 2024 | 17.00 Mn |
| Sep 30, 2024 | 17.00 Mn |
| Jun 30, 2024 | -20.00 Mn |
| Jun 30, 2024 | -20.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Mar 31, 2024 | -5.00 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Dec 31, 2023 | -7.00 Mn |